Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas

Cancer Res. 1987 Oct 1;47(19):5074-9.


A tumor-specific antigen (TSA) expressed on the chemically induced BALB/c Meth A sarcoma and one of 22 other BALB/c sarcomas tested, CMS13, was detected in in vitro cellular and humoral assays. The distribution pattern of the TSA defined in a complement-dependent microcytoxicity assay by cytotoxic antibodies present in CMS13 antisera was similar to that detected by a cytotoxic T-cell clone, designated CTLL-MA10B, in an 18-h cell-mediated cytotoxicity assay. The serologically defined TSA was shown to be expressed on gp96, a Mr 96,000 glycoprotein isolated from Meth A cytosol with immunoprotective activity in in vivo tumor rejection assays. Immunization of BALB/c mice with Meth A, CMS13, or preparations of gp96 isolated from these sarcomas induced tumor resistance in these mice to Meth A and CMS13 but not CMS5, an antigenically unrelated sarcoma. These results suggest that the shared TSA is expressed on gp96 and is functional in tumor rejection assays.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antigens, Neoplasm / analysis*
  • Cross Reactions
  • Cytotoxicity, Immunologic
  • Female
  • H-2 Antigens / genetics
  • Immune Sera / immunology
  • Interleukin-2 / physiology
  • Mice
  • Mice, Inbred BALB C
  • Sarcoma, Experimental / chemically induced
  • Sarcoma, Experimental / immunology*
  • T-Lymphocytes, Cytotoxic / immunology


  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • H-2 Antigens
  • Immune Sera
  • Interleukin-2